Back to Screener

The Joint Corp. (JYNT)

Price$8.79

Favorite Metrics

Price vs S&P 500 (26W)5.64%
Price vs S&P 500 (4W)2.81%
Market Capitalization$130.13M
P/E Ratio (Annual)44.76x

All Metrics

P/CF (Annual)70.78x
Book Value / Share (Quarterly)$1.06
P/TBV (Annual)7.19x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-18.47%
Cash Flow / Share (Quarterly)$0.02
Price vs S&P 500 (YTD)1.60%
Gross Margin (TTM)80.26%
Net Profit Margin (TTM)4.64%
EPS (TTM)$0.18
10-Day Avg Trading Volume0.03M
EPS Excl Extra (TTM)$0.18
Revenue Growth (5Y)-1.33%
EPS (Annual)$0.19
ROI (Annual)19.31%
Gross Margin (Annual)79.55%
Net Profit Margin (5Y Avg)-0.81%
Cash / Share (Quarterly)$1.67
P/E Basic Excl Extra (TTM)47.48x
Revenue Growth QoQ (YoY)-70.77%
EPS Growth (5Y)-26.64%
P/E Normalized (Annual)44.76x
ROA (Last FY)4.77%
Revenue Growth TTM (YoY)-70.57%
EBITD / Share (TTM)$0.09
ROE (5Y Avg)-4.25%
Operating Margin (TTM)-0.56%
Cash Flow / Share (Annual)$0.02
P/B Ratio8.64x
P/B Ratio (Quarterly)8.61x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)2.55x
Net Interest Coverage (TTM)81.13x
ROA (TTM)3.91%
EV / EBITDA (TTM)75.31x
EPS Incl Extra (Annual)$0.19
Current Ratio (Annual)1.59x
Quick Ratio (Quarterly)1.53x
3-Month Avg Trading Volume0.07M
52-Week Price Return-7.98%
EV / Free Cash Flow (Annual)318.27x
P/E Incl Extra (TTM)47.48x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$1.37
P/S Ratio (Annual)2.37x
Asset Turnover (Annual)0.90x
52-Week High$13.47
Operating Margin (5Y Avg)0.68%
EPS Excl Extra (Annual)$0.19
CapEx CAGR (5Y)-13.80%
Tangible BV CAGR (5Y)33.92%
26-Week Price Return14.39%
Quick Ratio (Annual)1.53x
13-Week Price Return-9.96%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)1.59x
Enterprise Value$106.532
Revenue / Share Growth (5Y)-2.04%
Asset Turnover (TTM)0.62x
Book Value / Share Growth (5Y)-6.53%
Revenue / Employee (Annual)$0
Pretax Margin (Annual)-0.42%
Cash / Share (Annual)$1.67
3-Month Return Std Dev37.88%
Gross Margin (5Y Avg)74.03%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)-29.46%
EBITDA Interim CAGR (5Y)-16.67%
ROE (Last FY)19.31%
Net Interest Coverage (Annual)-2963.10x
EPS Basic Excl Extra (Annual)$0.19
P/FCF (TTM)29.80x
Receivables Turnover (TTM)15.38x
EV / Free Cash Flow (TTM)318.27x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$0.18
Receivables Turnover (Annual)20.20x
ROI (TTM)13.55%
P/S Ratio (TTM)3.11x
Pretax Margin (5Y Avg)1.00%
Revenue / Share (Annual)$3.63
Tangible BV / Share (Annual)$1.34
Forward P/E47.69x
Free OCF CAGR (5Y)-47.02%
Price vs S&P 500 (52W)-43.08%
P/E Ratio (TTM)47.48x
Year-to-Date Return5.73%
5-Day Price Return3.95%
EPS Normalized (Annual)$0.19
ROA (5Y Avg)-0.80%
Net Profit Margin (Annual)5.30%
Month-to-Date Return4.18%
Cash Flow / Share (TTM)$0.65
EBITD / Share (Annual)$0.09
EPS Growth (3Y)68.30%
Operating Margin (Annual)-1.66%
LT Debt / Equity (Annual)0.00x
P/CF (TTM)70.78x
ROI (5Y Avg)-4.01%
P/E Excl Extra (TTM)47.48x
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$0.18
P/TBV (Quarterly)8.39x
P/B Ratio (Annual)8.61x
Pretax Margin (TTM)0.63%
Book Value / Share (Annual)$1.06
Price vs S&P 500 (13W)-12.83%
Net Margin Growth (5Y)-25.10%
Beta1.16x
P/FCF (Annual)388.79x
Revenue / Share (TTM)$2.85
ROE (TTM)13.55%
52-Week Low$7.50

Analyst Recommendations

Jan 2026
Feb 2026
Mar 2026
Apr 2026
3.80
3.80
3.80
3.80

Industry Peers — Patent Owners & Lessors(10)

SymbolP/E Ratio (Annual)Indicated Dividend Yield (Annual)ROE (TTM)P/B Ratio (Quarterly)Price
JYNTThe Joint Corp.
44.76x13.55%8.61x$8.79
IDCCInterDigital, Inc.
23.57x0.75%38.50%7.44x$368.95
DLBDolby Laboratories, Inc.Class A
24.20x2.22%9.26%2.42x$64.77
ACTGAcacia Research Corporation
22.29x4.02%0.66x$4.97
APPSDigital Turbine, Inc.
-30.34%2.88x$3.81
VHCVirnetX Holding Corp Common Stock
-60.10%3.17x$17.78
RMCORoyalty Management Holding Corporation Class A Common Stock
0.35%-5.22%3.42x$2.98
REFRResearch Frontiers Inc
-122.90%47.21x$1.00
NTIPNetwork-1 Technologies, Inc.
6.94%-5.87%0.76x$1.44
AMODAlpha Modus Holdings, Inc. Class A Common Stock
4.43x4.95%$0.38
XELBXCEL BRANDS INC.
-78.55%0.29x$2.24

About

The Joint Corp operates and franchises chiropractic clinics across the United States, generating revenue primarily through franchise licenses and management arrangements. The company operates directly-owned clinics while supporting a network of franchised locations where doctors of chiropractic provide personalized pain relief and preventative care. Its business model leverages franchising to expand market reach while reducing capital requirements for expansion.